Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP937984.RAVlxbyt9V6R42CNzVj2rsEBn9Y-LGmjSKxRX_YeIHWwk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP937984.RAVlxbyt9V6R42CNzVj2rsEBn9Y-LGmjSKxRX_YeIHWwk130_assertion type Assertion NP937984.RAVlxbyt9V6R42CNzVj2rsEBn9Y-LGmjSKxRX_YeIHWwk130_head.
- NP937984.RAVlxbyt9V6R42CNzVj2rsEBn9Y-LGmjSKxRX_YeIHWwk130_assertion description "[Loss of PTEN was recently shown to contribute to resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) in EGFR mutation-positive non-small cell lung cancer (NSCLC) through activation of the protein kinase AKT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP937984.RAVlxbyt9V6R42CNzVj2rsEBn9Y-LGmjSKxRX_YeIHWwk130_provenance.
- NP937984.RAVlxbyt9V6R42CNzVj2rsEBn9Y-LGmjSKxRX_YeIHWwk130_assertion evidence source_evidence_literature NP937984.RAVlxbyt9V6R42CNzVj2rsEBn9Y-LGmjSKxRX_YeIHWwk130_provenance.
- NP937984.RAVlxbyt9V6R42CNzVj2rsEBn9Y-LGmjSKxRX_YeIHWwk130_assertion SIO_000772 22075159 NP937984.RAVlxbyt9V6R42CNzVj2rsEBn9Y-LGmjSKxRX_YeIHWwk130_provenance.
- NP937984.RAVlxbyt9V6R42CNzVj2rsEBn9Y-LGmjSKxRX_YeIHWwk130_assertion wasDerivedFrom befree-2016 NP937984.RAVlxbyt9V6R42CNzVj2rsEBn9Y-LGmjSKxRX_YeIHWwk130_provenance.
- NP937984.RAVlxbyt9V6R42CNzVj2rsEBn9Y-LGmjSKxRX_YeIHWwk130_assertion wasGeneratedBy ECO_0000203 NP937984.RAVlxbyt9V6R42CNzVj2rsEBn9Y-LGmjSKxRX_YeIHWwk130_provenance.